People

Karl Hecker has joined PerkinElmer as director of research and development for its Boston-based center of excellence, the firm said this week. Hecker joins PerkinElmer from Invitrogen.

He will be responsible for leading all product R&D efforts for molecular medicine within the company's life and analytical sciences unit. Hecker holds a PhD in biochemistry from Florida State University.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.